American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. Issue 2 (10th January 2021)
- Record Type:
- Journal Article
- Title:
- American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. Issue 2 (10th January 2021)
- Main Title:
- American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care
- Authors:
- Pennell, Nathan A.
Dillmon, Melissa
Levit, Laura A.
Moushey, E. Allyn
Alva, Ajjai S.
Blau, Sibel
Cannon, Timothy L.
Dickson, Natalie R.
Diehn, Maximilian
Gonen, Mithat
Gonzalez, Maria Magdalena
Hensold, Jack O.
Hinyard, Leslie J.
King, Tari
Lindsey, Stacie C.
Magnuson, Allison
Marron, Jonathan
McAneny, Barbara L.
McDonnell, Theresa M.
Mileham, Kathryn Finch
Nasso, Shelley Fuld
Nowakowski, Grzegorz S.
Oettel, Kurt R.
Patel, Manali I.
Patt, Debra A.
Perlmutter, Jane
Pickard, Todd A.
Rodriguez, Gladys
Rosenberg, Abby R.
Russo, Barry
Szczepanek, Connie
Smith, Cardinale B.
Srivastava, Piyush
Teplinsky, Eleonora
Thota, Ramya
Traina, Tiffany A.
Zon, Robin
Bourbeau, Brian
Bruinooge, Suanna S.
Foster, Shelagh
Grubbs, Stephen
Hagerty, Karen
Hurley, Patricia
Kamin, Deborah
Phillips, Jonathan
Schenkel, Caroline
Schilsky, Richard L.
Burris, Howard A.
… (more) - Abstract:
- Abstract : This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for moving forward as the pandemic recedes. ASCO organized its recommendations for clinical research around five goals to ensure lessons learned from the COVID-19 experience are used to craft a more equitable, accessible, and efficient clinical research system that protects patient safety, ensures scientific integrity, and maintains data quality. The specific goals are: (1) ensure that clinical research is accessible, affordable, and equitable; (2) design more pragmatic and efficient clinical trials; (3) minimize administrative and regulatory burdens on research sites; (4) recruit, retain, and support a well-trained clinical research workforce; and (5) promote appropriate oversight and review of clinical trial conduct and results. Similarly, ASCO also organized its recommendations regarding cancer care delivery around five goals: (1) promote and protect equitable access to high-quality cancer care; (2) support safe delivery of high-quality cancer care; (3) advance policies to ensure oncology providers have sufficient resources to provide high-quality patient care; (4) recognize and address threats to clinician, provider, and patient well-being; and (5) improve patient access to high-quality cancer care via telemedicine. ASCOAbstract : This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for moving forward as the pandemic recedes. ASCO organized its recommendations for clinical research around five goals to ensure lessons learned from the COVID-19 experience are used to craft a more equitable, accessible, and efficient clinical research system that protects patient safety, ensures scientific integrity, and maintains data quality. The specific goals are: (1) ensure that clinical research is accessible, affordable, and equitable; (2) design more pragmatic and efficient clinical trials; (3) minimize administrative and regulatory burdens on research sites; (4) recruit, retain, and support a well-trained clinical research workforce; and (5) promote appropriate oversight and review of clinical trial conduct and results. Similarly, ASCO also organized its recommendations regarding cancer care delivery around five goals: (1) promote and protect equitable access to high-quality cancer care; (2) support safe delivery of high-quality cancer care; (3) advance policies to ensure oncology providers have sufficient resources to provide high-quality patient care; (4) recognize and address threats to clinician, provider, and patient well-being; and (5) improve patient access to high-quality cancer care via telemedicine. ASCO will work at all levels to advance the recommendations made in this report. … (more)
- Is Part Of:
- Journal of clinical oncology. Volume 39:Issue 2(2021)
- Journal:
- Journal of clinical oncology
- Issue:
- Volume 39:Issue 2(2021)
- Issue Display:
- Volume 39, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 39
- Issue:
- 2
- Issue Sort Value:
- 2021-0039-0002-0000
- Page Start:
- 155
- Page End:
- 169
- Publication Date:
- 2021-01-10
- Subjects:
- Oncology -- Periodicals
Cancer -- Periodicals
Oncology
Medical Oncology
Cancérologie -- Périodiques
Cancer -- Périodiques
Cancérologie
Cancer
Oncology
Oncologia
Càncer
Periodicals
616.994 - Journal URLs:
- http://www.jco.org/ ↗
http://jco.ascopubs.org/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1200/JCO.20.02953 ↗
- Languages:
- English
- ISSNs:
- 0732-183X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24132.xml